SNPX: Synaptogenix Company Short-Term Debt
This daily price chart for Synaptogenix, Inc. (SNPX) reflects a dependence on FDA verdicts and the inflow of external funding, with the metric standing at 0.00. The business relies on developing synapse recovery agents for Alzheimer's, protected by patents for bryostatin-1. The current R&D stage focuses on neural tissue regeneration, rendering the company's developments strategically significant for modern medicine.
Financial and market metric breakdowns for Synaptogenix, Inc (SNPX)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Debt to Equity Synaptogenix, Inc.|SNPX - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Synaptogenix, Inc.|SNPX - Company Aggregate Debts|Debt to Book Capitalization Ratio Synaptogenix, Inc.|SNPX - Long-Term Liabilities|Company Current Liabilities Synaptogenix|Quick Liquidity synaptogen.com
- earnings and multiples data:
Analysis of all company metrics:SNPX - Synaptogenix
Fundamental asset screening requires precise liquidity monitoring, where short-term liabilities maturing within one year determine the stability of the operating cycle. By analyzing the history of short-term liabilities, an investor assesses the default risk and the dependence of Synaptogenix, Inc. (SNPX) on external financing, which is critical for the development of Alzheimer's drugs that remain independent of economic cycles and seasonal fluctuations.
Key competitors
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Short-Term Debt ACADIA Pharmaceuticals|xenon-pharma.com (XENE) - Short-Term Debt Volume|Company Current Liabilities VKTX (Viking Therapeutics, Inc.)|SUPN - Short-Term Debt|Company Short-Term Debt Catalyst Pharmaceuticals Inc CPRX|DNLI: Company Short-Term Indebtedness|Harmony Biosciences - Company Short-Term Debts|BHVN - Company Short-Term Debts|Amylyx Pharmaceuticals, Inc. (AMLX) - Company Short-Term Debt|Current Liabilities TRVI (Trevi Therapeutics Inc)|Company Current Liabilities PRAX|AVXL (Anavex Life Sciences Corp) - Amount of Current Liabilities|Company Short-Term Debt CeriBell, Inc. (CBLL)|PRTA - Short-Term Debt|Company Short-Term Debts ALEC (Alector)|Short-Term Indebtedness Annexon Biosciences|Omeros Corp. - Company Short-Term Debts|Short-Term Debt Neurogene Therapeutics|AC Immune (ACIU) - Company Short-Term Debt|Company Short-Term Indebtedness VYGR|NMRA (Neumora Therapeutics, Inc.) - Company Short-Term Debts|Scilex Holding (SCLX) - Short-Term Debt Volume|Company Current Liabilities TVGN (Tevogen Bio Holdings, Inc.)|alphacognition.com - Company Short-Term Indebtedness|Cognition Therapeutics, Inc. - Company Current Liabilities|Company Short-Term Loans and Borrowings IKT|Cassava Sciences - Company Short-Term Debts|Short-Term Debt Volume Assertio Holdings, Inc. ASRT|coyatherapeutics.com (COYA) - Company Short-Term Debt|Company Short-Term Indebtedness VTGN|OVID (Ovid Therapeutics Inc) - Company Short-Term Debts|Company Current Liabilities acumenpharm.com (ABOS)|Company Current Liabilities CRVO (CervoMed)|Short-Term Debt Volume alteritytherapeutics.com|Company Short-Term Debt Clene CLNN|Short-Term Debt Volume PepGen Inc (PEPG)|JUNS - Company Short-Term Debt|RLMD (relmada.com) - Company Short-Term Indebtedness|Annovis Bio (ANVS) - Company Short-Term Debt|Current Liabilities GRCE (Grace Therapeutics)|Company Current Liabilities AIFF|Company Short-Term Indebtedness KLTO (ANEW Medical, Inc.)|Company Short-Term Debt NeuroSense Therapeutics (NRSN)|revivapharma.com - Company Short-Term Indebtedness|Company Short-Term Debts MTVA (MetaVia)|NeurAxis Inc. (NRXS) - Short-Term Debt|HSDT: Company Current Liabilities|PASG - Company Short-Term Debts|bionomics.com.au (NEUP) - Company Short-Term Debt|minervaneurosciences.com - Company Short-Term Loans and Borrowings|Company Short-Term Debt Athira Pharma|Short-Term Debt Addex Therapeutics Ltd. ADXN|Company Short-Term Debt Alzamend Neuro, Inc. (ALZN)|Short-Term Debt Volume cyclerion.com|Protagenic Therapeutics, Inc. - Company Current Liabilities|Pasithea Therapeutics Corp (KTTA) - Short-Term Debt|CRGT - Company Short-Term Debt|ATXI (Avenue Therapeutics Inc.) - Company Short-Term Indebtedness|BCLI: Company Short-Term Debts|Cara Therapeutics Inc (CARA) - Company Short-Term Debts|Company Short-Term Debt Chromocell Therapeutics|Eliem - Current Liabilities|Company Current Liabilities ITCI (Intra-Cellular Therapies)|Amount of Current Liabilities LBPH|Company Short-Term Debt Marinus MRNS|NKGen Biotech Corp (NKGN) - Short-Term Debt|NeuroBo Pharmaceuticals - Company Short-Term Debts|Short-Term Indebtedness sagerx.com (SAGE)|TRVN: Company Short-Term Debts|Short-Term Debt Vigil Neuroscience, Inc. (VIGL)|Company Short-Term Debt Anew Medical, Inc.|Company Short-Term Indebtedness CERE (Cerevel Corp)